Anders Waage

Anders Waage

UNVERIFIED PROFILE

Are you Anders Waage?   Register this Author

Register author
Anders Waage

Anders Waage

Publications by authors named "Anders Waage"

Are you Anders Waage?   Register this Author

83Publications

1182Reads

-Profile Views

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2019 01 10;10(1):213. Epub 2019 Jan 10.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-08107-8
Publisher Site
http://dx.doi.org/10.1038/s41467-018-08107-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328616PMC
January 2019

Correction: amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.

Oncotarget 2018 Nov 13;9(89):36048. Epub 2018 Nov 13.

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267601PMC
November 2018

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2018 09 13;9(1):3707. Epub 2018 Sep 13.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-04989-w
Publisher Site
http://dx.doi.org/10.1038/s41467-018-04989-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137048PMC
September 2018

[Research takes time].

Tidsskr Nor Laegeforen 2018 08 21;138(12). Epub 2018 Aug 21.

View Article

Download full-text PDF

Source
https://tidsskriftet.no/2018/08/debatt/forskning-tar-tid
Publisher Site
http://dx.doi.org/10.4045/tidsskr.18.0436DOI Listing
August 2018

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients.

Oncotarget 2018 Aug 10;9(62):32024-32035. Epub 2018 Aug 10.

Department of Clinical and Molecular Medicine, Myeloma Research Center, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112830PMC
August 2018

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes.

Biomark Res 2018 14;6:21. Epub 2018 Jun 14.

1Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40364-018-0134-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001014PMC
June 2018

A Gain-of-Function Mutation in EPO in Familial Erythrocytosis.

N Engl J Med 2018 03;378(10):924-930

From the Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel (J.Z., P.L., R.N., R.C.S.), and Diagnostic Hematology, University Hospital Basel (P.L.), Basel, Switzerland; and the Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (M.L.T., A.S., A.W.), and the Department of Hematology, St. Olavs Hospital (A.W.) - both in Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709064DOI Listing
March 2018

Monitoring multiple myeloma by quantification of recurrent mutations in serum.

Haematologica 2017 07 6;102(7):1266-1272. Epub 2017 Apr 6.

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.160564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566041PMC
July 2017

Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.

Oncotarget 2017 Mar;8(12):19427-19442

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/14294
Publisher Site
http://dx.doi.org/10.18632/oncotarget.14294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386695PMC
March 2017

VOLIN and KJON-Two novel hyperdiploid myeloma cell lines.

Genes Chromosomes Cancer 2016 11 12;55(11):890-901. Epub 2016 Jul 12.

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22388DOI Listing
November 2016

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells.

Oncotarget 2016 Oct;7(43):70845-70856

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342593PMC
October 2016

Congenital thrombotic thrombocytopenic purpura.

Tidsskr Nor Laegeforen 2016 09 27;136(17):1452-7. Epub 2016 Sep 27.

Institutt for kreftforskning og molekylær medisin Norges teknisk-naturvitenskapelige universitet Trondheim og Avdeling for blodsykdommer St. Olavs hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4045/tidsskr.15.1272DOI Listing
September 2016

Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma.

Leuk Lymphoma 2015 11;56(9):2650-9. Epub 2015 Feb 11.

a Department of Hematology , Rigshospitalet, University of Copenhagen , Copenhagen , Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1004168DOI Listing
August 2016

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.

J Hematol Oncol 2016 08 31;9(1):75. Epub 2016 Aug 31.

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0306-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007700PMC
August 2016

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy.

PLoS One 2015 7;10(10):e0139867. Epub 2015 Oct 7.

KG Jebsen Centre for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; CEMIR, Centre of Molecular Immune Regulation, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139867PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596870PMC
June 2016

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease.

Haematologica 2015 Dec 20;100(12):e511-4. Epub 2015 Aug 20.

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.124511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666344PMC
December 2015

Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression.

Genes Chromosomes Cancer 2015 Nov 29;54(11):692-701. Epub 2015 Jul 29.

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644988PMC
November 2015

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.

Oncotarget 2015 Sep;6(26):22698-705

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673192PMC
September 2015

ADAMTS13 gene variants and function in women with preeclampsia: a population- based nested case- control study from the HUNT Study.

Thromb Res 2015 Aug 18;136(2):282-8. Epub 2015 Jun 18.

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Haematology, St Olavs Hospital Trondheim University Hospital, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2015.06.022DOI Listing
August 2015

The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma.

Immun Inflamm Dis 2015 Jun 2;3(2):94-102. Epub 2015 Mar 2.

K.G. Jebsen Center for Myeloma Research Trondheim, Norway ; Department for Cancer Research and Molecular Medicine, Center for Molecular Inflammation Research NTNU, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/iid3.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444152PMC
June 2015

Health-related quality of life in patients with multiple myeloma--does it matter?

Haematologica 2015 Jun;100(6):704-5

Department of Hematology, Department of Medicine, St Olavs University Hopsital, and Jebsen Center for Myeloma Research, Institute of Cancer Research and Moleclar Medicine, Norwegian University of Science and Technology, Trondheim, Norway

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.127860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450614PMC
June 2015

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.

Cell Commun Signal 2015 Jun 6;13:27. Epub 2015 Jun 6.

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Post box 8905, MTFS, N-7491, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12964-015-0104-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467681PMC
June 2015

Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma.

Biol Blood Marrow Transplant 2015 May 14;21(5):840-7. Epub 2015 Feb 14.

Immunology Research group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.12.027DOI Listing
May 2015

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.

Lancet 2015 Apr 5;385(9978):1653-61. Epub 2015 Feb 5.

Haematology Department, Oslo University Hospital and Institute of Clinical Medicine, Oslo University, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)61495-1DOI Listing
April 2015

The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications.

Thromb Haemost 2014 Jun 6;111(6):1180-3. Epub 2014 Feb 6.

Anne-Sophie von Krogh, Department of Haematology, St Olavs Hospital Trondheim University Hospital, PO Box 3250 Sluppen, N-7006 Trondheim, Norway, Tel.: +47 72825367/ +47 48233320, Fax: + 47 72825733, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH13-08-0713DOI Listing
June 2014

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients.

Biomark Res 2014 Apr 9;2(1). Epub 2014 Apr 9.

The K. G. Jebsen Center for Myeloma Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2050-7771-2-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022385PMC
April 2014

Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.

Eur J Haematol 2013 Oct 20;91(4):339-46. Epub 2013 Aug 20.

Department of Cancer Research and Molecular Medicine, KG Jebsen Center for Myeloma Research, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12176DOI Listing
October 2013

A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.

J Biomol Screen 2013 Jul 27;18(6):637-46. Epub 2013 Feb 27.

KG Jebsen Center for Myeloma Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087057113478168DOI Listing
July 2013

HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.

Exp Hematol 2013 Jul 14;41(7):646-55. Epub 2013 Mar 14.

KG Jebsen Center for Myeloma Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.03.002DOI Listing
July 2013

Addiction to c-MYC in multiple myeloma.

Blood 2012 Sep 17;120(12):2450-3. Epub 2012 Jul 17.

KG Jebsen Center for Myeloma Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-08-371567DOI Listing
September 2012

Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease.

Histopathology 2012 Feb;60(3):443-51

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2011.04112.xDOI Listing
February 2012

[Treatment of myeloma when high dose therapy is not possible. New drugs--alternatives for elderly patients].

Lakartidningen 2011 Oct 19-25;108(42):2090-4

Radiumhemmet, Karolinska universitetssjukhuset, Solna.

View Article

Download full-text PDF

Source
December 2011

Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters.

Eur J Haematol 2011 Nov 16;87(5):394-9. Epub 2011 Aug 16.

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1600-0609.2011.01622.x
Publisher Site
http://dx.doi.org/10.1111/j.1600-0609.2011.01622.xDOI Listing
November 2011

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma.

Eur J Haematol 2009 Nov 31;83(5):460-70. Epub 2009 Jul 31.

Department of Biomaterials, Institute for Clinical Dentistry, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01311.xDOI Listing
November 2009

FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).

Eur J Haematol 2009 Nov 6;83(5):471-6. Epub 2009 Jul 6.

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gt. 9, N-7489 Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01312.xDOI Listing
November 2009

c-Met signaling promotes IL-6-induced myeloma cell proliferation.

Eur J Haematol 2009 Apr 6;82(4):277-87. Epub 2009 Jan 6.

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://www.biomedsearch.com/attachments/00/19/18/72/19187270
Web Search
http://doi.wiley.com/10.1111/j.1600-0609.2009.01212.x
Publisher Site
http://dx.doi.org/10.1111/j.1600-0609.2009.01212.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704927PMC
April 2009

Mn2+ regulates myeloma cell adhesion differently than the proadhesive cytokines HGF, IGF-1, and SDF-1alpha.

Eur J Haematol 2008 Dec 4;81(6):437-47. Epub 2008 Sep 4.

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01148.xDOI Listing
December 2008

Thalidomide for treatment of multiple myeloma: 10 years later.

Blood 2008 Apr 1;111(8):3968-77. Epub 2008 Feb 1.

Division of Hematology, University of Torino, Azienda Ospedaliera S Giovanni Battista, Torino, Italy.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2007-10-11
Publisher Site
http://dx.doi.org/10.1182/blood-2007-10-117457DOI Listing
April 2008

Hepatocyte growth factor promotes migration of human myeloma cells.

Haematologica 2008 Apr 6;93(4):619-22. Epub 2008 Mar 6.

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, MTFS, N-7489 Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11867DOI Listing
April 2008

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.

Blood 2008 Jan 12;111(2):806-15. Epub 2007 Oct 12.

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, and Department of Immunology and Transfusion Medicine, St Olavs University Hospital, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-07-101139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200854PMC
January 2008

[In hundred years everything will be known].

Authors:
Anders Waage

Tidsskr Nor Laegeforen 2007 Oct;127(20):2680

Avdeling for blodsykdommer, Medisinsk klinikk, St. Olavs Hospital, 7006 Trondheim.

View Article

Download full-text PDF

Source
October 2007

Bone disease in multiple myeloma.

Med Oncol 2006 ;23(4):431-41

Department of Haematology, St. Olav University Hospital, Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology N-7006 Trondheim, Norway.

View Article

Download full-text PDF

Source
March 2007

Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor.

Haematologica 2005 Apr;90(4):479-88

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, MTFS, N-7489 Trondheim, Norway.

View Article

Download full-text PDF

Source
April 2005

A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma.

Haematologica 2004 May;89(5):552-6

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, MTFS, N-7489 Trondheim, Norway.

View Article

Download full-text PDF

Source
May 2004

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.

Oncogene 2004 Apr;23(17):3024-32

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim N-7489, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207386DOI Listing
April 2004

Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.

Haematologica 2004 Feb;89(2):174-82

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
February 2004

[Cancer--the inner enemy].

Authors:
Anders Waage

Tidsskr Nor Laegeforen 2003 Apr;123(7):972; author reply 972

View Article

Download full-text PDF

Source
April 2003

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor.

Blood 2002 Dec 18;100(12):3925-9. Epub 2002 Jul 18.

Institute of Cancer Research and Molecular Biology, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-05-1406DOI Listing
December 2002

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy.

Br J Haematol 2002 Dec;119(3):672-6

Department of IMPI, Division of Pathology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
December 2002

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.

Blood 2002 Oct;100(8):3002-7

Institute of Cancer Research and Molecular Biology, Faculty of Medicine, Norwegian University of Science and Technology, Medisinsk Teknisk Senter, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2002-04-11
Publisher Site
http://dx.doi.org/10.1182/blood-2002-04-1190DOI Listing
October 2002

Interleukin-21 is a growth and survival factor for human myeloma cells.

Blood 2002 May;99(10):3756-62

Department of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
May 2002

Perfusion abnormalities in pulmonary embolism studied with perfusion MRI and ventilation-perfusion scintigraphy: an intra-modality and inter-modality agreement study.

J Magn Reson Imaging 2002 Apr;15(4):386-94

Department of Medicine, University Hospital of Trondheim, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
April 2002

Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4.

Circulation 2002 Feb;105(6):685-90

Faculty of Medicine, Institute of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
February 2002